Framing the research agenda for sickle cell trait: Building on the current understanding of clinical events and their potential implications

American Journal of Hematology

Volumn 87, Issue 3, 2012, Pages 340-346

  Goldsmith, Jonathan C ^a   Bonham, Vence L ^b   Joiner, Clinton H ^c   Kato, Gregory J ^a   Noonan, Allan S ^d   Steinberg, Martin H ^e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d MORGAN STATE UNIVERSITY   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN;

AFRICA; ARMY; ATHLETE; BEHAVIORAL SCIENCE; BIOETHICS; CHILDHOOD DISEASE; CONFERENCE PAPER; ENDEMIC DISEASE; EXERCISE; HEALTH HAZARD; HEREDITY; HUMAN; INCIDENCE; KIDNEY FAILURE; MALARIA FALCIPARUM; MEDICAL ETHICS; MUSCLE FUNCTION; NEOPLASM; PATIENT COUNSELING; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; SICKLE CELL; SICKLE CELL TRAIT; SKELETAL MUSCLE; SOCIOLOGY; SUDDEN DEATH; THROMBOEMBOLISM; UNITED STATES; VEIN THROMBOSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AFRICA; AFRICAN AMERICANS; ATHLETES; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN; DISEASE MANAGEMENT; EXERCISE; FEMALE; HUMANS; INFANT; MALE; MILITARY PERSONNEL; MUSCLE, SKELETAL; NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; RENAL INSUFFICIENCY; RESEARCH; RISK; SICKLE CELL TRAIT; SPLENIC INFARCTION; THROMBOEMBOLISM; THROMBOPHILIA; UNITED STATES;

EID: 84857045310     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22271     Document Type: Conference Paper

References (99)

1. World Health Organization. Executive Board, 117th Session, Provisional agenda item 4.8, EB117/34 (22 December 2005) or World Health Organization. 59th World Health Assembly A59/9 Provisional agenda item 11.4 (24 April 2006).
2. Piel FB, Patil AP, Howes RE, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun 2010; 1104: 1-7.
3. Aidoo M, Terlouw DJ, Kolczak M, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002; 359: 1311-1312.
4. Williams TN, Mwangi TW, Wambua S, et al. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 2005; 192: 178-186.
5. Makani J, Komba AN, Cox SE, et al. Malaria in patients with sickle cell anemia: Burden, risk factors, and outcome at the outpatient clinic and during hospitalization. Blood 2010; 115: 215-220.
6. World Health Organization. Sickle-cell anaemia: Report by the Secretariat. World Health Organization, Fifty-Ninth World Health Assembly A59/9, Provisional agenda item 11.4 (24 April 2006).
7. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final Data for 2007. National Vital Statistics Reports; 58 (number 24) National Center for Health Statistics: 1-77 (August 9, 2010).
8. Tsaras G, Owusu-Ansah A, Owusua Boateng F, Amoateng-Adjepong Y. Complications associated with sickle cell trait: A brief narrative review. Am J Med 2009; 122: 507-512.
9. Minneapolis Heart Institute Foundation.
10. Maron BJ, Doerer JJ, Haas TS, et al. Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009; 119: 1085-1092.
11. Wang L, Seidman JG, Seidman CE. Narrative review: Harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy. Ann Int Med 2010; 152: 513-520.
12. Hedley PL, Jorgensen P, Schlamowitz S, et al. The genetic basis of long QT and short QT syndromes: A mutation update. Hum Mutat 2009; 30: 1486-1511.
13. IOC Medical Commission. IOC preparticipation cardiovascular screening. December 10, 2004. Available at: Accessed on November 11, 2007.
14. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation 2007; 115: 1643-1655.
15. Joyner MJ, Green DJ. Exercise protects the cardiovascular system: Effects beyond traditional risk factors. J Physiol 2009; 587: 5551-5558.
16. Ama PFM, Simoneau JA, Boulay MR, et al. Skeletal muscle characteristics in sedentary Black and Caucasian males. J Appl Physiol 1986; 61: 1758-1761.
17. Tanner CJ, Barakat HA, Dohm GL, et al. Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrin Metab 2002; 282: E1191-E1196.
18. Hsu YD, Lee WH, Chang MK, et al. Blood lactate threshold and type II fibre predominance in patients with exertional heatstroke. J Neurol Neurosurg Psychiatry 1997; 62: 182-187.
19. Sambuughin N, Capacchione J, Blokhin A, et al. The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility. Clin Genet 2009; 76: 564-568.
20. Burke A, Creighton W, Mont E, et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 2005; 112: 798-802.
21. Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med 1987; 317: 781-787.
22. Kark JA, Burr PQ, Wenger CB, et al. Exertional heat illness in Marine Corps recruits training. Aviat Space Environ Med 1996; 67: 354-360.
23. Gardner JW, Karnei K, Sanborn JS, et al. Risk factors predicting exertional heat illness in male Marine Corps recruits. Med Sci Sports Exerc 1996; 28: 939-944.
24. Eichner ER. Sickle cell trait in sports. Curr Sports Med Rep 2010; 9: 347-351.
25. Hartley LH, Vogel JA, Landowne M. Central, femoral, and brachial circulation during exercise in hypoxia. J Appl Physiol 1973; 34: 87-90.
26. Martin TW, Weisman IDM, Zeballos RJ, Stephenson SR. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait. Am J Med 1989; 87: 48-56.
27. Vincent L, Feasson L, Oyono-Enguelle S, et al. Remodeling of skeletal muscle microvasculature in sickle cell trait and alpha-thalassemia. Am J Physiol-Heart Circ Physiol 2010; 298: H375-H384.
28. Tripette J, Loko G, Samb A, et al. Effects of hydration and dehydration on blood rheology in sickle cell trait carriers during exercise. Am J Physiol-Heart Circ Physiol 2010; 299: H908-H914.
29. The National Athletic Trainers' Association (NATA) releases "Sickle Cell Trait and the Athlete" Consensus Statement: Knowledge of sickle cell trait status can be a gateway to education; recommendations offered to reduce the risk of collapse during sports and exercise; Available at: ( 2007).
30. NCAA News/Division I. Protocol decided for sickle cell testing; Available at: ( 2010).
31. Thogmartin JR, Wilson CI, Palma NA, et al. Histological diagnosis of sickle cell trait: A blinded analysis. Am J Forensic Med Pathol 2009; 30: 36-39.
32. Kass NE. An ethics framework for public health. Am J Public Health 2001; 91: 1776-1782.
33. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009; 361: 1651-1661.
34. Whitten CF. Sickle-cell programming-An imperiled promise. N Engl J Med 1973; 288: 318-319.
35. Bonham VL, Dover GJ, Brody LC. Screening student athletes for sickle cell trait-a social and clinical experiment. N Engl J Med 2010; 363: 997-999.
36. Weatherall MW, Higgs DR, Weiss H, et al. Phenotype/genotype relationships in sickle cell disease: A pilot twin study. Clin Lab Haem 2005; 27: 384-390.
37. Acharya K, Walsh Lang C, Friedman Ross L. A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease. J Natl Med Assn 2009; 101: 1163-1172.
38. Diggs LW, Ahmann CF, Bibb J. The incidence and significance of the sickle cell trait. Ann Int Med 1933; 7: 769-778.
39. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, a molecular disease. Science 1949; 110: 543-548.
40. Scott RB. Historical review of legislative and national initiatives for sickle cell disease. Am J Pediatr Hematol Oncol 1983; 5: 346-351.
41. Neal-Cooper F, Scott RB. Genetic counseling in sickle cell anemia: Experiences with couples at risk. Public Health Rep 1988; 103: 174-178.
42. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med 1986; 314: 1593-1599.
43. National Newborn Screening Information System at National Newborn Screening and Genetics Resource Center; Available at: ( 2005).
44. Rowley PT. Genetic screening: Marvel or menace? Science 1984; 225: 138-144.
45. Proceedings of the First National Symposium on Sickle Cell Disease, NHLI & NIH, Bethesda, MD, June 1974. DHEW Publication No. (NIH) 75-723.
46. Advisory Committee on Heritable Disorders in Newborns and Children. Letter to the Secretary, US Department of Health and Human Services re: Sickle Cell Trait and Disease screening of NCAA athletes; Available at: ( 2010).
47. Cornwall A, Jewkes R. What is participatory research? Soc Sci Med 1995; 41: 1667-1676.
48. Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: Assessing partnership approaches to improve public health. Annu Rev Public Health 1998; 19: 173-202.
49. Bookchin M, Balazs T, Landau LC. Determinants of red cell sickling: Effects of varying pH and of increasing intracellular hemoglobin concentration by osmotic shrinkage. J Lab Clin Med 1976; 87: 597-616.
50. Noguchi CT, Torchia DA, Schechter AN. Polymerization of hemoglobin in sickle trait erythrocytes and lysates. J Biol Chem 1981; 256: 4168-4171.
51. Martin TW, Weisman IM, Zeballos RJ, Stephenson SR. Exercise and hypoxia increase sickling in venous blood from an exercising limb in individuals with sickle cell trait. Am J Med 1989; 87: 48-56.
52. Bergeron MF, Cannon JG, Hall EL, Kutlar A. Erythrocyte sickling during exercise and thermal stress. Clin J Sport Med 2004; 14: 354-356.
53. Lonsdorfer J, Bogui P, Otayeck A, et al. Cardiorespiratory adjustments in chronic sickle cell anemia. Bull Eur Physiopathol Respir 1983; 19: 339-344.
54. Mozzarelli A, Hofrichter J, Eaton WA. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 1987; 237: 500-506.
55. Connes P, Sara F, Hardy-Dessources M-D, et al. Effects of short supramaximal exercise on hemorheology in sickle cell trait carriers. Eur J Appl Physiol 2006; 97: 143-150.
56. Monchanin G, Serpero LD, Connes P, et al. Effects of progressive and maximal exercise on plasma levels of adhesion molecules in athletes with sickle cell trait with or without alpha-thalassemia. J Appl Physiol 2007; 102: 169-173.
57. Heller P, Best WR, Nelson RB, Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 1979; 300: 1001-1005.
58. Westerman MP, Green D, Gilman-Sachs A, et al. Coagulation changes in individuals with sickle cell trait. Am J Hematol 2002; 69: 89-94.
59. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood 2007; 110: 908-912.
60. Austin H, Lally C, Benson JM, et al. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol 2009; 200: 620.e1-630.e3.
61. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: Potentially pathogenic agents and diagnostic markers. Trans Med Rev 2006; 20: 1-26.
62. Adams JQ. Sudden death in pregnancy due to the sickle cell trait. South Med J 1957; 50: 898-901.
63. Pastorek JC, Seiler B. Maternal death associated with sickle cell trait. Am J Obstet Gynecol 1985; 151: 295-297.
64. Dunn A, Eckert G, King P, Matthews R. Intraoperative death during Caesarian section in a patient with sickle-cell trait. Can J Anaesth 1987; 34: 67-70.
65. Tollin SR, Seely EW. Postpartum hypopituitarism in a patient with sickle cell trait. Am J Med Sci 1994; 308: 35-37.
66. Santana Ribeiro JA, da Rocha Lucena D, Da Rocha Lucena L, Jorge R. Proliferative sickle cell retinopathy associated with sickle cell trait and gestational diabetes: case report. Arq Bras Oftalmol 2009; 72: 400-402.
67. Whalley PJ, Martin FG, Pritchard JA. Sickle cell trait and urinary tract infection during pregnancy. JAMA 1964; 189: 903-906.
68. Baill IC, Witter FR. Sickle trait and its association with birthweight and urinary tract infections in pregnancy. Int J Gynecol Obstet 1990; 33: 19-21.
69. Thurman AR, Steed LL, Hulsey T, Soper DE. Bacteriuria in pregnant women with sickle cell trait. Am J Obstet Gynecol 2006; 194: 1366-1370.
70. Miller JM. Sickle cell trait in pregnancy. South Med J 1983; 76: 962-965.
71. Larrabee KD, Monga M. Women with sickle cell trait are at increased risk for preeclampsia. Am J Obstet Gynecol 1997; 177: 425-428.
72. Stamilio DM, Sehdev HM, Macones GA. Pregnant women with sickle cell trait are not at increased risk for developing preeclampsia. Am J Perinatol 2003; 20: 41-48.
73. Tita ATN, Biggio JR, Chapman V, et al. Perinatal and maternal outcomes in women with sickle or hemoglobin C trait. Obstet Gynecol 2007; 110: 1113-1119.
74. Adeyemi AB, Adediran IA, Kuti O, et al. Outcome of pregnancy in a population of Nigerian women with sickle cell trait. J Obstet Gynaecol 2006; 26: 133-137.
75. Taylor MY, Wyatt-Ashmead J, Gray J, et al. Pregnancy loss after first-trimester viability in women with sickle cell trait: Time for a reappraisal? Am J Obstet Gynecol 2006; 194: 1604-1608.
76. Taylor MY, Wyatt-Ashmead J, Gray J, et al. Pregnancy loss after first trimester viability in women with sickle cell trait: A preliminary report. South Med J 2008; 101: 150-151.
77. Statius van Eps LW, Earley LE. The kidney in sickle cell disease. In: Earley LE, Gottschalk CW, editors. Strauss and Welt's Diseases of the Kidney, 3rd ed. Philadelphia: W.B. Saunders; 1979. pp 1229-1240.
78. Bleyer AJ, Reddy Sv, Sujata L, et al. Sickle cell trait and development of microvascular complications in diabetes mellitus. Clin J Am Soc Nephrol 2010; 5: 1015-1020.
79. Oli JM, Watkins PJ, Wild B, Adegoke OJ. Albuminuria in Afro-Caribbeans with type 2 diabetes mellitus: Is the sickle trait a risk factor? Diabet Med 2004; 21: 483-486.
80. Ajayi AA, Kolawole BA. Sickle cell trait and gender influence type 2 diabetic complications in African patients. Eur J Int Med 2004; 15: 312-315.
81. Derebail VK, Nachman PH, Key NS, et al. High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol 2010; 21: 413-417.
82. Yium J, Gabow P, Johnson A, et al. Autosomal dominant polycystic kidney disease in blacks: Clinical course and effects of sickle-cell hemoglobin. J Am Soc Nephrol 1994; 4: 1670-1674.
83. Davis CJJr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma: The seventh sickle cell nephropathy. Am J Surg Pathol 1995; 19: 1-11.
84. Dimashkieh J, Choe J, Mutema G. Renal medullary carcinoma: A report of 2 cases and review of the literature. Arch Pathol Lab Med 2003; 127: e135-e138.
85. Simpson L, He X, Pins M, et al. Renal medullary carcinoma and abl gene amplification. J Urol 2005; 173: 1883-1888.
86. Wantanabe IC, Billis A, Guimaraes MS, et al. Renal medullary carcinoma: A report of seven cases from Brazil. Mod Pathol 2007; 20: 914-920.
87. McAuley CF, Webb C, Makani J, et al. High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya. Blood 2010; 116: 1663-1668.
88. Cooley JC, Peterson WL, Engel CE. Clinical triad of massive splenic infarction, sicklemia trait, and high altitude flying. JAMA 1954; 154: 111-113.
89. Franklin QJ, Compeggie M. Splenic syndrome in sickle cell trait: Four case presentations and a review of the literature. Mil Med 1999; 164: 230-233.
90. Hassell K. Personal Communication. University of Colorado Sickle Cell Center; 2010.
91. Poehling KA, Light LS, Rhodes M, et al. Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease. Epidemiology 2010; 21: 340-346.
92. Amoateng-Adjepong Y. Commentary-Is sickle cell trait a risk factor for invasive pneumococcal disease? Epidemiology 2010; 21: 347-348.
93. Golomb MR. Sickle cell trait is a risk factor for early stroke. Arch Neurol 2005; 62: 1778-1779.
94. Dowling M. Sickle cell trait is not a risk factor for stroke. Arch Neurol 2005; 62: 1780-1781.
95. Lannuzel A, Salmon V, Mevel G, et al. Epidemiology of stroke in Guadeloupe and role for sickle cell trait. Revue Neurologique (Paris) 1999; 155: 351-356.
96. Klein HG, Anstee DJ, editors. Blood Transfusion in Clinical Medicine (Mollison's Eleventh Edition). Malden: Blackwell Publishing; 2005. p 6.
97. Stroncek DF, Rainer T, Sharon V, et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion 2002; 42: 1466-1472.
98. Byrne KM, Leitman SF, Schechter AN, Stroncek DF. Increasing oxygen tension improves filtration of sickle trait donor blood. Br J Haematol 2003; 122: 678-681.
99. Shaping the Future of Research: A Strategic Plan for the National Heart, Lung, and Blood Institute. NIH Publication No. 07-6150 (September 2007).